• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

大环内酯类药物对生物膜中人类多形核白细胞与铜绿假单胞菌相互作用的体外效应。

The in vitro effect of macrolides on the interaction of human polymorphonuclear leukocytes with Pseudomonas aeruginosa in biofilm.

作者信息

Takeoka K, Ichimiya T, Yamasaki T, Nasu M

机构信息

Second Department of Internal Medicine, Oita Medical University, Japan.

出版信息

Chemotherapy. 1998 May-Jun;44(3):190-7. doi: 10.1159/000007114.

DOI:10.1159/000007114
PMID:9612609
Abstract

The in vitro effect of macrolides at concentrations below the minimum inhibitory concentration (sub-MIC) on the interaction between Pseudomonas aeruginosa biofilm and human polymorphonuclear leukocytes (PMNs) was investigated by using a chemiluminescence assay. The PMN response to either mucoid or nonmucoid P. aeruginosa biofilm was strongly reduced compared with the response to planktonic bacteria (p < 0.01, p < 0.001, respectively). When biofilms were treated with erythromycin, clarithromycin, roxithromycin and azithromycin prior to incubation with PMNs, the chemiluminescence response was markedly enhanced as compared to untreated controls, and a dose-dependent effect was noted over the range of sub-MIC concentrations studied. In general, macrolides appeared to be slightly more active against mucoid biofilm. Azithromycin was shown to be the most active macrolide against P. aeruginosa biofilms. However, the treatment with sub-MICs of rokitamycin did not have any effect. On the other hand, treatment of planktonic bacteria with macrolides before being exposed to the PMNs did not affect the chemiluminescence response as compared to untreated controls. These findings suggest that macrolides inhibiting the biofilm formation of P. aeruginosa may facilitate the phagocytosis of bacteria by PMNs.

摘要

采用化学发光分析法研究了大环内酯类药物在低于最低抑菌浓度(亚 MIC)时对铜绿假单胞菌生物膜与人类多形核白细胞(PMN)之间相互作用的体外效应。与对浮游细菌的反应相比,PMN 对黏液型或非黏液型铜绿假单胞菌生物膜的反应显著降低(分别为 p < 0.01,p < 0.001)。在用 PMN 孵育之前,用红霉素、克拉霉素、罗红霉素和阿奇霉素处理生物膜,与未处理的对照相比,化学发光反应明显增强,并且在所研究的亚 MIC 浓度范围内观察到剂量依赖性效应。一般来说,大环内酯类药物对黏液型生物膜的活性似乎略高。阿奇霉素被证明是对铜绿假单胞菌生物膜活性最高的大环内酯类药物。然而,用罗他霉素的亚 MIC 处理没有任何效果。另一方面,与未处理的对照相比,在用 PMN 接触之前用大环内酯类药物处理浮游细菌不会影响化学发光反应。这些发现表明,抑制铜绿假单胞菌生物膜形成的大环内酯类药物可能促进 PMN 对细菌的吞噬作用。

相似文献

1
The in vitro effect of macrolides on the interaction of human polymorphonuclear leukocytes with Pseudomonas aeruginosa in biofilm.大环内酯类药物对生物膜中人类多形核白细胞与铜绿假单胞菌相互作用的体外效应。
Chemotherapy. 1998 May-Jun;44(3):190-7. doi: 10.1159/000007114.
2
[Effect of macrolides on biofilm of mucoid Pseudomonas aeruginosa].[大环内酯类药物对黏液型铜绿假单胞菌生物被膜的影响]
Zhonghua Yi Xue Za Zhi. 2001 Aug 10;81(15):934-6.
3
In-vitro effects of antimicrobial agents on Pseudomonas aeruginosa biofilm formation.抗菌剂对铜绿假单胞菌生物膜形成的体外作用。
J Antimicrob Chemother. 1994 Sep;34(3):331-41. doi: 10.1093/jac/34.3.331.
4
[Inhibitory effect of macrolide antibiotics on biofilm formation by Pseudomonas aeruginosa].[大环内酯类抗生素对铜绿假单胞菌生物膜形成的抑制作用]
Nihon Jibiinkoka Gakkai Kaiho. 1998 Jan;101(1):25-36. doi: 10.3950/jibiinkoka.101.25.
5
Antipseudomonal agents exhibit differential pharmacodynamic interactions with human polymorphonuclear leukocytes against established biofilms of Pseudomonas aeruginosa.抗假单胞菌药物与人类多形核白细胞针对铜绿假单胞菌已形成的生物膜表现出不同的药效学相互作用。
Antimicrob Agents Chemother. 2015 Apr;59(4):2198-205. doi: 10.1128/AAC.04934-14. Epub 2015 Feb 2.
6
The influence of azithromycin on the biofilm formation of Pseudomonas aeruginosa in vitro.阿奇霉素对铜绿假单胞菌体外生物膜形成的影响。
Chemotherapy. 1996 May-Jun;42(3):186-91. doi: 10.1159/000239440.
7
Effect of azithromycin, roxithromycin and erythromycin on human polymorphonuclear leukocyte function against Staphylococcus aureus.阿奇霉素、罗红霉素和红霉素对人多形核白细胞抗金黄色葡萄球菌功能的影响。
Chemotherapy. 1990;36(6):422-7. doi: 10.1159/000238799.
8
Effects of rokitamycin on phagocytosis and release of oxidant radicals of human polymorphonuclear leukocytes.
Chemotherapy. 1997 May-Jun;43(3):190-7. doi: 10.1159/000239560.
9
Potential of macrolide antibiotics to inhibit protein synthesis of Pseudomonas aeruginosa: suppression of virulence factors and stress response.大环内酯类抗生素抑制铜绿假单胞菌蛋白质合成的潜力:对毒力因子和应激反应的抑制作用
J Infect Chemother. 2000 Mar;6(1):1-7. doi: 10.1007/s101560050042.
10
Interaction of macrolides and ketolides with the phagocytic cell line PLB-985.大环内酯类和酮内酯类与吞噬细胞系PLB-985的相互作用。
J Chemother. 2003 Aug;15(4):350-6. doi: 10.1179/joc.2003.15.4.350.

引用本文的文献

1
A Rabbit Model to Study Antibiotic Penetration at the Site of Infection for Nontuberculous Mycobacterial Lung Disease: Macrolide Case Study.用于研究非结核分枝杆菌肺病感染部位抗生素渗透的兔模型:大环内酯案例研究。
Antimicrob Agents Chemother. 2022 Mar 15;66(3):e0221221. doi: 10.1128/aac.02212-21. Epub 2022 Jan 31.
2
Antimicrobial susceptibility of hospital acquired Stenotrophomonas maltophilia isolate biofilms.医院获得性嗜麦芽窄食单胞菌分离株生物膜的抗菌药敏性
Braz J Infect Dis. 2016 Jul-Aug;20(4):365-73. doi: 10.1016/j.bjid.2016.04.002. Epub 2016 May 13.
3
Evaluation of tumour necrosis factor-alpha and interleukin-1beta in an experimental pyelonephritis model induced with planktonic and biofilms cells of Pseudomonas aeruginosa.
评价浮游菌和生物膜状态下铜绿假单胞菌诱导的实验性肾盂肾炎模型中的肿瘤坏死因子-α和白细胞介素-1β。
Can J Infect Dis Med Microbiol. 2009 Fall;20(3):e35-42. doi: 10.1155/2009/810791.
4
Role of macrolide therapy in chronic obstructive pulmonary disease.大环内酯类药物治疗在慢性阻塞性肺疾病中的作用。
Int J Chron Obstruct Pulmon Dis. 2008;3(3):331-50. doi: 10.2147/copd.s681.
5
Absolute bioavailability and intracellular pharmacokinetics of azithromycin in patients with cystic fibrosis.阿奇霉素在囊性纤维化患者中的绝对生物利用度和细胞内药代动力学。
Antimicrob Agents Chemother. 2005 Dec;49(12):5013-7. doi: 10.1128/AAC.49.12.5013-5017.2005.
6
Characterization of cell-to-cell signaling-deficient Pseudomonas aeruginosa strains colonizing intubated patients.对定植于插管患者体内的细胞间信号传导缺陷型铜绿假单胞菌菌株的特性分析。
J Clin Microbiol. 2004 Feb;42(2):554-62. doi: 10.1128/JCM.42.2.554-562.2004.